NovellusDx

NovellusDx

NovellusDx

NovellusDx is dedicated to delivering the actionable intelligence that oncologists require to choose the right therapy for each patient.
Founded
2012
Raised
$18.5M
Follow us
Alexa global traffic share
Latest funding Show all
$6,000,000
Venture capital - 2018
Windham Venture Partners Helsinn Investment Fund S.A. SICAR Bio Capital Impact Fund
$2,500,000
Venture capital - 2016
OrbiMed
Team Size
1–10
Employees
$6,000,000 Venture capital
FinSMEs , PE HUB

NovellusDx Completes $6M Equity Financing

Funding Science Health
$2,500,000 Venture capital
SmartBrief

NovellusDx funding round hits $12.5M

$10,000,000 Venture capital
Geektime.com

NovellusDx ropes home $10 million for its cancer solution